Login to Your Account



Hopes to Partner This Year

Optimer Reports More Good Data for Phase III Fidaxomicin

By Catherine Hollingsworth


Monday, February 8, 2010
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription